Grants

W15-010: Evaluating new drug compounds for treating feline coronavirus

Given successes in antiviral therapeutics for HIV, many researchers studying feline infectious peritonitis (FIP) consider antiviral therapy the brightest hope for successful treatment. In addition, rapidly emerging research into related human-animal coronaviruses SARS and MERS has paved the way for dramatic advances in FIP therapeutics. Through optimizing laboratory methods, drug compounds with demonstrated effects against SARS and MERS will be tested for their efficacy against FIP. A FIP-specific enzyme will also be isolated and produced to create a more sophisticated screening test for such drug compounds. Although FIP is a great challenge, the intent is to identify drug compounds that will successfully treat FIP. (General Study: Sponsored)

Grant ID: W15-010

Status: Active

Year Funded: 2015

Amount awarded: $14,970

Investigator: Brian Murphy, DVM, PhD, ACVP; Niels Pedersen, DVM, PhD; University of California, Davis